SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : LUNR (lunar corp)
LUNR 11.37-5.4%3:59 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paul Getman who wrote (15)8/11/1997 10:57:00 PM
From: crysball   of 29
 
Visited LUNR recently.

It's interesting to note that sales of both LUNR and HOLX axial Densitiometer product lines have flattened.

LUNR's Q3 sales growth actually came from the the NMR product they import.

LUNR is also introducing a low cost peripheral X-ray screening densitometer for the Calcaneous [heel], which is FDA approved, but no reimbursement is set yet.. However Norland and HOLX are alos in this makret.

There also seems to be some question if HOLX is manipulating their #'s by dumping inventory into the distribution channels
{Japan the March ending quarter and the US the June ending Quarter. If this is a fact HOLX may have to pay the piper in the next quarter,,,,,,,,since there is only som much inventory a distributor can afford to carry.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext